#protein viscosity reduction

Discover 2 curated intelligence briefings related to this specific topic.

The Great Cellular Purge: Senolytics Move from Mouse Models to Human Bedside
Health & Medicine

The Great Cellular Purge: Senolytics Move from Mouse Models to Human Bedside

From the STOP-Sepsis trials in the US to plant-derived longevity research in South Korea, the shift in senolytic therapy is moving away from general anti-aging and toward treating specific, high-stakes pathologies.

Read Analysis
Protein Aggregation Ends Where Precision Formulation Begins
Technology & Innovation

Protein Aggregation Ends Where Precision Formulation Begins

High-concentration protein formulations are the bottleneck of modern biologics. This technical execution guide details the precise methods to suppress molecular aggregation and manage exponential viscosity increases in monoclonal antibody delivery.

Read Analysis